2 hours Corvus Pharmaceuticals (NASDAQ:CRVS) Downgraded to “Sell” at StockNews.com MarketBeat
StockNews.com lowered shares of Corvus Pharmaceuticals from a “hold” rating to a “sell” rating in a report on Friday.
StockNews.com lowered shares of Corvus Pharmaceuticals from a “hold” rating to a “sell” rating in a report on Friday.